Literature DB >> 8940180

Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.

A Alessandrini1, H Greulich, W Huang, R L Erikson.   

Abstract

MAP (mitogen-activated protein) kinases are activated by a family of dual specificity kinases called Meks (MAP kinase/Erk kinase). Mek1 can be activated by Raf by phosphorylation on serine 218 and serine 222. Mutation of these sites to acidic residues leads to constitutively active Mek1 in some cases. When fibroblast lines were infected with high titer retroviral stocks carrying these Mek1 genes, the resultant transformation and morphological changes correlated with the kinase activity of the respective Mek1 enzymes. Although [Asp218]- and [Asp218,Asp222]Mek immunoprecipitated from clonal cell lines could phosphorylate kinase-inactive Erk1 equally well in vitro, the endogenous MAP kinase activity was 5-7-fold greater in [Asp218]Mek1-infected clonal lines, and did not correlate with the degree of transformation. Analysis of the Erk1 pathway revealed Raf-1 activation, which correlated qualitatively with the MAP kinase activity seen in the [Asp218]- and [Asp218,Asp222]Mek1-infected clonal cell lines. Expression of dominant negative Ras did not affect the elevated Raf-1 activity observed in these cells, however. These data suggest that Mek1 phosphorylation site mutants activate Raf-1 and MAP kinase by a Ras-independent pathway and that the mechanism by which transformation occurs may utilize pathways that are MAP kinase-independent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940180     DOI: 10.1074/jbc.271.49.31612

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.

Authors:  Paul E Hughes; Beat Oertli; Malene Hansen; Fan-Li Chou; Berthe M Willumsen; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

2.  ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo.

Authors:  Patty J Lee; Xuchen Zhang; Peiying Shan; Bing Ma; Chun Geun Lee; Robert J Homer; Zhou Zhu; Mercedes Rincon; Brooke T Mossman; Jack A Elias
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

3.  Spatial phosphoprotein profiling reveals a compartmentalized extracellular signal-regulated kinase switch governing neurite growth and retraction.

Authors:  Yingchun Wang; Feng Yang; Yi Fu; Xiahe Huang; Wei Wang; Xinning Jiang; Marina A Gritsenko; Rui Zhao; Matthew E Monore; Olivier C Pertz; Samuel O Purvine; Daniel J Orton; Jon M Jacobs; David G Camp; Richard D Smith; Richard L Klemke
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

4.  Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.

Authors:  J A Frost; H Steen; P Shapiro; T Lewis; N Ahn; P E Shaw; M H Cobb
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions.

Authors:  Marcel Schilling; Thomas Maiwald; Stefan Hengl; Dominic Winter; Clemens Kreutz; Walter Kolch; Wolf D Lehmann; Jens Timmer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2009-12-22       Impact factor: 11.429

6.  MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia.

Authors:  A Alessandrini; S Namura; M A Moskowitz; J V Bonventre
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.

Authors:  Jun Zhu; Vitaly Balan; Agnieszka Bronisz; Karina Balan; Hengrui Sun; Deborah T Leicht; Zhijun Luo; Jun Qin; Joseph Avruch; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

8.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

9.  Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

Authors:  J Turkson; T Bowman; J Adnane; Y Zhang; J Y Djeu; M Sekharam; D A Frank; L B Holzman; J Wu; S Sebti; R Jove
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

10.  RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

Authors:  Gorjan Hrustanovic; Victor Olivas; Evangelos Pazarentzos; Asmin Tulpule; Saurabh Asthana; Collin M Blakely; Ross A Okimoto; Luping Lin; Dana S Neel; Amit Sabnis; Jennifer Flanagan; Elton Chan; Marileila Varella-Garcia; Dara L Aisner; Aria Vaishnavi; Sai-Hong I Ou; Eric A Collisson; Eiki Ichihara; Philip C Mack; Christine M Lovly; Niki Karachaliou; Rafael Rosell; Jonathan W Riess; Robert C Doebele; Trever G Bivona
Journal:  Nat Med       Date:  2015-08-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.